160 related articles for article (PubMed ID: 25123977)
1. Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication.
Marotta V; Di Somma C; Rubino M; Sciammarella C; Del Prete M; Marciello F; Ramundo V; Circelli L; Buonomano P; Modica R; Vitale M; Colao A; Faggiano A
Endocrine; 2015 May; 49(1):274-8. PubMed ID: 25123977
[No Abstract] [Full Text] [Related]
2. Cinacalcet as symptomatic treatment of hypercalcaemia in primary hyperparathyroidism prior to surgery.
Misiorowski W; Zgliczyński W
Endokrynol Pol; 2017; 68(3):306-310. PubMed ID: 28660989
[TBL] [Abstract][Full Text] [Related]
3. Dramatic Regression of Parathyroid Gland Swelling After Conversion of Calcimimetic Medication From Cinacalcet to Etelcalcetide.
Yoshimura K; Funakoshi Y; Terawaki H
Ther Apher Dial; 2018 Oct; 22(5):553-554. PubMed ID: 29927050
[No Abstract] [Full Text] [Related]
4. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS
Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515
[TBL] [Abstract][Full Text] [Related]
5. Changes in bone mineral metabolism parameters, including FGF23, after discontinuing cinacalcet at kidney transplantation.
Barros X; Fuster D; Paschoalin R; Oppenheimer F; Rubello D; Perlaza P; Pons F; Torregrosa JV
Endocrine; 2015 May; 49(1):267-73. PubMed ID: 25154517
[TBL] [Abstract][Full Text] [Related]
6. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation.
Gulcan-Kersin S; Kirkgoz T; Eltan M; Rzayev T; Ata P; Bilgen H; Ozek E; Bereket A; Turan S
Horm Res Paediatr; 2020; 93(5):313-321. PubMed ID: 33147586
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet.
Guerra R; Auyanet I; Fernández EJ; Pérez MÁ; Bosch E; Ramírez A; Suria S; Checa MD
J Nephrol; 2011; 24(1):78-82. PubMed ID: 20437396
[TBL] [Abstract][Full Text] [Related]
8. Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.
Takeuchi Y; Takahashi S; Miura D; Katagiri M; Nakashima N; Ohishi H; Shimazaki R; Tominaga Y
J Bone Miner Metab; 2017 Nov; 35(6):616-622. PubMed ID: 27873072
[TBL] [Abstract][Full Text] [Related]
9. Acute pseudogout after cinacalcet treatment.
Grana E; Da Costa F de Frias Pinto A; Carda S
Kidney Int; 2018 Oct; 94(4):831-832. PubMed ID: 30243323
[No Abstract] [Full Text] [Related]
10. Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism.
Ruderman I; Smith ER; Toussaint ND; Hewitson TD; Holt SG
BMC Nephrol; 2018 May; 19(1):113. PubMed ID: 29764395
[TBL] [Abstract][Full Text] [Related]
11. Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy.
Koman A; Ohlsson S; Bränström R; Pernow Y; Bränström R; Nilsson IL
Br J Surg; 2019 Dec; 106(13):1810-1818. PubMed ID: 31595982
[TBL] [Abstract][Full Text] [Related]
12. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
[TBL] [Abstract][Full Text] [Related]
13. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of parathyroid levels and bone densitometry after cinacalcet treatment in severe primary hyperparathyroidism.
Ogrin C
Minerva Endocrinol; 2013 Sep; 38(3):337-8. PubMed ID: 24126554
[No Abstract] [Full Text] [Related]
15. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Block GA; Bushinsky DA; Cheng S; Cunningham J; Dehmel B; Drueke TB; Ketteler M; Kewalramani R; Martin KJ; Moe SM; Patel UD; Silver J; Sun Y; Wang H; Chertow GM
JAMA; 2017 Jan; 317(2):156-164. PubMed ID: 28097356
[TBL] [Abstract][Full Text] [Related]
16. Cinacalcet as an alternative to phosphate therapy in X-linked hypophosphataemic rickets.
Alon US; Jarka D; Monachino PJ; Sebestyen VanSickle J; Srivastava T
Clin Endocrinol (Oxf); 2017 Jul; 87(1):114-116. PubMed ID: 28382624
[No Abstract] [Full Text] [Related]
17. Cinacalcet for the treatment of primary hyperparathyroidism.
Dillon ML; Frazee LA
Am J Ther; 2011 Jul; 18(4):313-22. PubMed ID: 20228675
[TBL] [Abstract][Full Text] [Related]
18. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.
Silverberg SJ; Rubin MR; Faiman C; Peacock M; Shoback DM; Smallridge RC; Schwanauer LE; Olson KA; Klassen P; Bilezikian JP
J Clin Endocrinol Metab; 2007 Oct; 92(10):3803-8. PubMed ID: 17666472
[TBL] [Abstract][Full Text] [Related]
19. Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature.
Vera L; Oddo S; Di Iorgi N; Bentivoglio G; Giusti M
J Med Case Rep; 2016 Dec; 10(1):361. PubMed ID: 27998296
[TBL] [Abstract][Full Text] [Related]
20. Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report.
Gonzalo García I; Robles Fradejas M; Martín Macías MLA; Biain Ciganda A; Bustinza Beaskoetxea Z; Ruiz Pérez E; Fernández Matia G; Martínez Guisasola J
J Obstet Gynaecol; 2018 Jan; 38(1):132-134. PubMed ID: 28760052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
